Format

Send to

Choose Destination
Int J Drug Policy. 2017 Sep;47:47-50. doi: 10.1016/j.drugpo.2017.05.054. Epub 2017 Jul 6.

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.

Author information

1
CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. Electronic address: Jeffrey.Lazarus@regionh.dk.
2
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
3
Cermes3, Inserm U988/CNRS UMR 8211, EHESS, Paris Descartes University, Paris, France.
4
Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
5
European Liver Patients' Association, Brussels, Belgium.
6
Correlation Network, Amsterdam, the Netherlands.
7
European AIDS Treatment Group, Brussels, Belgium.
8
Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
PMID:
28689856
DOI:
10.1016/j.drugpo.2017.05.054
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center